vTv Therapeutics, Inc. (VTVT)
30.58
+0.12
(+0.38%)
USD |
NASDAQ |
Sep 16, 16:00
30.58
0.00 (0.00%)
After-Hours: 20:00
vTv Therapeutics Market Cap : 120.43M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 119.98M |
| September 14, 2026 | 123.84M |
| September 11, 2026 | 125.92M |
| September 10, 2026 | 125.49M |
| September 09, 2026 | 131.12M |
| September 08, 2026 | 129.15M |
| September 04, 2026 | 131.36M |
| September 03, 2026 | 131.83M |
| September 02, 2026 | 131.56M |
| September 01, 2026 | 125.84M |
| August 31, 2026 | 126.04M |
| August 28, 2026 | 127.46M |
| August 27, 2026 | 129.19M |
| August 26, 2026 | 132.23M |
| August 25, 2026 | 133.56M |
| August 24, 2026 | 133.49M |
| August 21, 2026 | 130.98M |
| August 20, 2026 | 130.30M |
| August 19, 2026 | 129.57M |
| August 18, 2026 | 123.99M |
| August 17, 2026 | 123.32M |
| August 14, 2026 | 118.64M |
| August 13, 2026 | 121.51M |
| August 12, 2026 | 125.18M |
| August 11, 2026 | 130.14M |
| Date | Value |
|---|---|
| August 10, 2026 | 135.06M |
| August 07, 2026 | 139.32M |
| August 06, 2026 | 136.32M |
| August 05, 2026 | 135.46M |
| August 04, 2026 | 126.28M |
| August 03, 2026 | 127.57M |
| July 31, 2026 | 127.42M |
| July 30, 2026 | 128.72M |
| July 29, 2026 | 123.99M |
| July 28, 2026 | 122.41M |
| July 27, 2026 | 122.18M |
| July 24, 2026 | 121.04M |
| July 23, 2026 | 124.70M |
| July 22, 2026 | 124.74M |
| July 21, 2026 | 129.62M |
| July 20, 2026 | 127.54M |
| July 17, 2026 | 129.50M |
| July 16, 2026 | 127.18M |
| July 15, 2026 | 128.76M |
| July 14, 2026 | 125.57M |
| July 13, 2026 | 124.38M |
| July 10, 2026 | 131.91M |
| July 09, 2026 | 131.71M |
| July 08, 2026 | 136.40M |
| July 07, 2026 | 134.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Spyre Therapeutics, Inc. | 8.033B |
| ACADIA Pharmaceuticals, Inc. | 4.737B |
| Alnylam Pharmaceuticals, Inc. | 32.03B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.056B |
Market Cap Related Metrics
| PS Ratio | 9.858 |
| Price to Book Value | 1.532 |
| Price | 30.58 |
| Earnings Yield | -3.46% |